{"SCHW": {"Ticker": "SCHW", "Company": "Charles Schwab Corporation", "Sector": "Financials", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$84"}, {"Date": "2022-10-19", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$80"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$83"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$83"}, {"Date": "2022-08-31", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$81"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Barclays", "Citigroup", "Credit Suisse"], "Price_Target": 82.2}, "DVA": {"Ticker": "DVA", "Company": "DaVita", "Sector": "Health Care", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$97 to $72"}, {"Date": "2022-10-31", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$117 to $74"}, {"Date": "2022-08-19", "Rating": "Resumed", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$106 to $117"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["UBS", "Deutsche Bank"], "Price_Target": 87.67}, "EMR": {"Ticker": "EMR", "Company": "Emerson Electric Company", "Sector": "Industrials", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$97 to $96"}, {"Date": "2022-08-17", "Rating": "Resumed", "Organization": "Bernstein", "Rating_Change": "Mkt Perform", "Target_Change": "$105 to $100"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Bernstein", "Deutsche Bank"], "Price_Target": 98.0}, "XOM": {"Ticker": "XOM", "Company": "ExxonMobil", "Sector": "Energy", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Upgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Underperform to Neutral", "Target_Change": "$115"}, {"Date": "2022-10-19", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$90 to $133"}, {"Date": "2022-08-11", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$125"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Exane BNP Paribas", "Jefferies", "Credit Suisse"], "Price_Target": 124.33}, "MNST": {"Ticker": "MNST", "Company": "Monster Beverage", "Sector": "Consumer Staples", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$96 to $106"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wedbush", "Rating_Change": "Neutral", "Target_Change": "$95"}, {"Date": "2022-08-05", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$100 to $98"}], "Score": 1.33, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["JP Morgan", "RBC Capital Mkts", "Wedbush"], "Price_Target": 99.67}, "NSC": {"Ticker": "NSC", "Company": "Norfolk Southern", "Sector": "Industrials", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Underperform to Sector Perform", "Target_Change": "$221 to $237"}, {"Date": "2022-10-07", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$280 to $240"}, {"Date": "2022-09-28", "Rating": "Downgrade", "Organization": "Susquehanna", "Rating_Change": "Positive to Neutral", "Target_Change": "$275 to $218"}, {"Date": "2022-09-27", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": ""}], "Score": -0.75, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Robert W. Baird", "UBS", "RBC Capital Mkts", "Susquehanna"], "Price_Target": 231.67}, "PFG": {"Ticker": "PFG", "Company": "Principal Financial Group", "Sector": "Financials", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$81 to $89"}, {"Date": "2022-10-31", "Rating": "Downgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Mkt Perform to Underperform", "Target_Change": "$75 to $77"}, {"Date": "2022-10-07", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Underweight", "Target_Change": "$69 to $72"}, {"Date": "2022-09-22", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Mkt Perform", "Target_Change": ""}, {"Date": "2022-08-18", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$82 to $86"}], "Score": -1.4, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Barclays", "Credit Suisse", "Keefe Bruyette", "Raymond James", "JP Morgan"], "Price_Target": 81.0}, "SYK": {"Ticker": "SYK", "Company": "Stryker Corporation", "Sector": "Health Care", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Downgrade", "Organization": "Canaccord Genuity", "Rating_Change": "Buy to Hold", "Target_Change": "$225 to $220"}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$239"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$270"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Barclays", "Canaccord Genuity", "Jefferies"], "Price_Target": 243.0}, "UAA": {"Ticker": "UAA", "Company": "Under Armour (Class A)", "Sector": "Consumer Discretionary", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$8"}, {"Date": "2022-10-21", "Rating": "Downgrade", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$12 to $8"}, {"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Mkt Perform", "Target_Change": ""}, {"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$12 to $10"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["BofA Securities", "Robert W. Baird", "Raymond James", "Telsey Advisory Group"], "Price_Target": 8.67}, "UNP": {"Ticker": "UNP", "Company": "Union Pacific", "Sector": "Industrials", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Underperform", "Target_Change": "$200 to $187"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$210 to $205"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$212 to $210"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "TD Securities", "Rating_Change": "Hold", "Target_Change": "$225 to $215"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "Susquehanna", "Rating_Change": "Neutral", "Target_Change": "$208 to $200"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "Raymond James", "Rating_Change": "Strong Buy", "Target_Change": "$230 to $220"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$219 to $217"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$244 to $232"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$207 to $204"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$210 to $207"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$235 to $220"}, {"Date": "2022-10-21", "Rating": "Reiterated", "Organization": "Argus", "Rating_Change": "Buy", "Target_Change": "$275 to $225"}, {"Date": "2022-09-14", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$234 to $230"}, {"Date": "2022-09-12", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$260"}, {"Date": "2022-08-26", "Rating": "Downgrade", "Organization": "Daiwa Securities", "Rating_Change": "Outperform to Neutral", "Target_Change": "$235 to $242"}], "Score": 0.4, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 15, "Period": "180 days", "Letter_Rating": "C", "Analists": ["UBS", "Barclays", "Argus", "RBC Capital Mkts", "Daiwa Securities", "TD Securities", "Credit Suisse", "Wells Fargo", "BofA Securities", "Susquehanna", "Raymond James", "JP Morgan", "Cowen", "Bernstein", "Citigroup"], "Price_Target": 218.27}, "VTR": {"Ticker": "VTR", "Company": "Ventas", "Sector": "Real Estate", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$63 to $48"}, {"Date": "2022-11-01", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Strong Buy to Outperform", "Target_Change": "$55 to $46"}, {"Date": "2022-10-10", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$38"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Raymond James", "Robert W. Baird", "Credit Suisse"], "Price_Target": 44.0}, "WELL": {"Ticker": "WELL", "Company": "Welltower", "Sector": "Real Estate", "Updated": "2022-11-01", "Rating": [{"Date": "2022-11-01", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$100 to $75"}, {"Date": "2022-11-01", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Strong Buy to Outperform", "Target_Change": "$81 to $70"}, {"Date": "2022-10-10", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$66"}, {"Date": "2022-08-31", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$90"}, {"Date": "2022-08-11", "Rating": "Downgrade", "Organization": "SMBC Nikko", "Rating_Change": "Outperform to Neutral", "Target_Change": "$84"}], "Score": 0.2, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["SMBC Nikko", "Credit Suisse", "Morgan Stanley", "Raymond James", "Robert W. Baird"], "Price_Target": 77.0}}